Beijing Tong Ren Tang Chinese Medicine Company Limited announced its monthly return for the period ended 30 November 2025, submitted on 1 December 2025. The document indicates that the company’s total number of issued ordinary shares remains at 837,100,000, with no treasury shares in the period. There has been no increase or decrease in share capital, and the balance is unchanged compared to the previous month.

The announcement states there were no share options issued, no warrants to issue new shares, no convertible securities, and no other agreements or arrangements to issue additional shares. The company further confirmed that, during the reporting month, there were no repurchases or redemptions of shares, and no Hong Kong Depositary Receipt activity recorded. All relevant confirmations and compliance requirements have been met under the applicable listing rules and regulations.